NY A04825 | 2011-2012 | General Assembly

Status

Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on February 8 2011 - 25% progression, died in chamber
Action: 2012-09-04 - enacting clause stricken
Text: Latest bill text (Introduced) [HTML]

Summary

Enacts the "genetically engineered pharmaceutical and industrial crop act"; prohibits the growth, sale, raising, transportation and cultivation of genetically engineered pharmaceutical or industrial crops; imposes a civil penalty of between $250,000 and $1,000,000 for any violation thereof; authorizes the attorney general to seek equitable relief against such violations; authorizes the attorney general or any aggrieved party to commence a civil action to recover compensatory and punitive damages.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Enacts the "genetically engineered pharmaceutical and industrial crop act"; prohibits the growth, sale, raising, transportation and cultivation of genetically engineered pharmaceutical or industrial crops; imposes a civil penalty of between $250,000 and $1,000,000 for any violation thereof; authorizes the attorney general to seek equitable relief against such violations; authorizes the attorney general or any aggrieved party to commence a civil action to recover compensatory and punitive damages.

Sponsors


History

DateChamberAction
2012-09-04Assemblyenacting clause stricken
2012-01-04Assemblyreferred to agriculture
2011-02-08Assemblyreferred to agriculture

New York State Sources


Bill Comments

feedback